Pages that link to "Q37088373"
Jump to navigation
Jump to search
The following pages link to MicroRNAs in metabolic disease (Q37088373):
Displaying 50 items.
- Nutrigenetics and Nutrimiromics of the Circadian System: The Time for Human Health (Q26765463) (← links)
- MicroRNA-206: a potential circulating biomarker candidate for amyotrophic lateral sclerosis (Q27321524) (← links)
- Bile acid signaling in metabolic disease and drug therapy (Q28244875) (← links)
- Controlling cholesterol synthesis beyond 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) (Q28291199) (← links)
- Dicer expression exhibits a tissue-specific diurnal pattern that is lost during aging and in diabetes (Q31144086) (← links)
- Transcriptional control of hepatic lipid metabolism by SREBP and ChREBP. (Q33672543) (← links)
- Exosomal miRNAs as potential biomarkers of cardiovascular risk in children (Q33756578) (← links)
- Down-regulation of miR-34a alleviates mesangial proliferation in vitro and glomerular hypertrophy in early diabetic nephropathy mice by targeting GAS1 (Q33865102) (← links)
- A pilot study of serum microRNAs panel as potential biomarkers for diagnosis of nonalcoholic fatty liver disease (Q34070770) (← links)
- Noncoding RNAs and atherosclerosis (Q34093095) (← links)
- microRNAs and HDL life cycle. (Q34248289) (← links)
- Long-term therapeutic silencing of miR-33 increases circulating triglyceride levels and hepatic lipid accumulation in mice (Q34342477) (← links)
- MicroRNAs: a connection between cholesterol metabolism and neurodegeneration (Q34613640) (← links)
- Risk-Association of DNMT1 Gene Polymorphisms with Coronary Artery Disease in Chinese Han Population (Q34834839) (← links)
- Analysis of serum miRNA profiles of myasthenia gravis patients. (Q35122838) (← links)
- Male obesity and subfertility, is it really about increased adiposity? (Q35604409) (← links)
- An overview of microRNAs (Q35858483) (← links)
- Dietary lipids modulate the expression of miR-107, an miRNA that regulates the circadian system (Q36115628) (← links)
- SREBP-1c/MicroRNA 33b Genomic Loci Control Adipocyte Differentiation (Q36709238) (← links)
- Systems Biology and Noninvasive Imaging of Atherosclerosis. (Q36884545) (← links)
- Effects of Tanshinone IIA on the modulation of miR‑33a and the SREBP‑2/Pcsk9 signaling pathway in hyperlipidemic rats (Q36931341) (← links)
- Identification and characterization of microRNAs in Baylisascaris schroederi of the giant panda (Q37053357) (← links)
- MicroRNA Profiling during Craniofacial Development: Potential Roles for Mir23b and Mir133b (Q37092620) (← links)
- Making sense in antisense: therapeutic potential of noncoding RNAs in diabetes-induced vascular dysfunction. (Q37393027) (← links)
- MicroRNA associated with dyslipidemia and coronary disease in humans (Q37440950) (← links)
- Blood hsa-miR-122-5p and hsa-miR-885-5p levels associate with fatty liver and related lipoprotein metabolism-The Young Finns Study (Q37472354) (← links)
- Massive analysis of cDNA Ends (MACE) and miRNA expression profiling identifies proatherogenic pathways in chronic kidney disease (Q37591528) (← links)
- Pivotal role of microRNA-33 in metabolic syndrome: A systematic review (Q37600199) (← links)
- MicroRNAs-Dependent Regulation of PPARs in Metabolic Diseases and Cancers. (Q37607478) (← links)
- c-Jun N-terminal kinase 1/c-Jun activation of the p53/microRNA 34a/sirtuin 1 pathway contributes to apoptosis induced by deoxycholic acid in rat liver. (Q37643931) (← links)
- microRNA regulation of lipoprotein metabolism. (Q37650119) (← links)
- IRS-2 Partially Compensates for the Insulin Signal Defects in IRS-1-/- Mice Mediated by miR-33. (Q37683511) (← links)
- microRNAs in lipoprotein metabolism and cardiometabolic disorders. (Q37709886) (← links)
- A Systematic Study of Dysregulated MicroRNA in Type 2 Diabetes Mellitus (Q37728970) (← links)
- Role of microRNAs in the treatment of type 2 diabetes mellitus with Roux-en-Y gastric bypass (Q37735780) (← links)
- Diabetic Cardiomyopathy: An Immunometabolic Perspective (Q37741735) (← links)
- MicroRNAs-Mediated Regulation of Skeletal Muscle GLUT4 Expression and Translocation in Insulin Resistance (Q37744073) (← links)
- MicroRNA-containing microvesicles regulating inflammation in association with atherosclerotic disease. (Q38115105) (← links)
- Mechanistic biomarkers in acetaminophen-induced hepatotoxicity and acute liver failure: from preclinical models to patients (Q38212434) (← links)
- Relevance of microRNA in metabolic diseases. (Q38230799) (← links)
- Atheroprotective effects of (poly)phenols: a focus on cell cholesterol metabolism (Q38264794) (← links)
- Aberrant expression of plasma microRNA-33a in an atherosclerosis-risk group (Q38290814) (← links)
- MicroRNA expression and its clinical implications in Ewing's sarcoma (Q38296481) (← links)
- Profiling peripheral microRNAs in obesity and type 2 diabetes mellitus (Q38299471) (← links)
- MicroRNA in intervertebral disc degeneration. (Q38367405) (← links)
- MicroRNA-mediated mechanisms of the cellular stress response in atherosclerosis (Q38412322) (← links)
- MicroRNAs in cardiovascular ageing (Q38514769) (← links)
- Circulating microRNAs and diabetes: potential applications in medical practice. (Q38544077) (← links)
- Metformin-suppressed differentiation of human visceral preadipocytes: Involvement of microRNAs (Q38747881) (← links)
- MicroRNAs in metabolism. (Q38786731) (← links)